These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27732635)

  • 21. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based Colonoscopy.
    Jen HH; Hsu CY; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Wu MS; Hsu WF; Peng SM; Chen HH; Chiu HM
    J Clin Gastroenterol; 2018 Oct; 52(9):821-827. PubMed ID: 29095416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model.
    Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M
    JAMA; 2015 Jun; 313(23):2349-58. PubMed ID: 26080339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
    Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
    BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
    Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
    Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal occult blood testing when colonoscopy capacity is limited.
    Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
    J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The optimal cut-off value in fit-based colorectal cancer screening: An observational study.
    Njor SH; Andersen B; Friis-Hansen L; de Haas N; Linnemann D; Nørgaard H; Roikjaer O; Søndergaard B; Rasmussen M
    Cancer Med; 2021 Mar; 10(5):1872-1879. PubMed ID: 33534955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer screening by colonoscopy: putting it into perspective.
    Vleugels JL; van Lanschot MC; Dekker E
    Dig Endosc; 2016 Apr; 28(3):250-9. PubMed ID: 26257272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
    Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
    Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attendance and yield over three rounds of population-based fecal immunochemical test screening.
    Kapidzic A; Grobbee EJ; Hol L; van Roon AH; van Vuuren AJ; Spijker W; Izelaar K; van Ballegooijen M; Kuipers EJ; van Leerdam ME
    Am J Gastroenterol; 2014 Aug; 109(8):1257-64. PubMed ID: 24980879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).
    Portillo I; Arana-Arri E; Idigoras I; Bilbao I; Martínez-Indart L; Bujanda L; Gutierrez-Ibarluzea I
    World J Gastroenterol; 2017 Apr; 23(15):2731-2742. PubMed ID: 28487610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.
    Powell AA; Saini SD; Breitenstein MK; Noorbaloochi S; Cutting A; Fisher DA; Bloomfield HE; Halek K; Partin MR
    J Gen Intern Med; 2015 Jun; 30(6):732-41. PubMed ID: 25605531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial results of the National Colorectal Cancer Screening Program in Lithuania.
    Poskus T; Strupas K; Mikalauskas S; Bitinaitė D; Kavaliauskas A; Samalavicius NE; Saladzinskas Z
    Eur J Cancer Prev; 2015 Mar; 24(2):76-80. PubMed ID: 25370682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices.
    McNamara D; Qasim A; Lee N; Condon C; O'Morain C
    Ir J Med Sci; 2011 Jun; 180(2):549-52. PubMed ID: 21264524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand.
    van Turenhout ST; Terhaar sive Droste JS; Meijer GA; Masclée AA; Mulder CJ
    BMC Cancer; 2012 Jan; 12():46. PubMed ID: 22280408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies.
    Hoffman RM; Stone SN; Herman C; Jung AM; Cotner J; Espey D; Kozoll R; Gavin MW
    Prev Chronic Dis; 2005 Jan; 2(1):A07. PubMed ID: 15670460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of primary care physician counseling on participation rate and use of sedation in colonoscopy-based colorectal cancer screening program--a randomized controlled study.
    Boguradzka A; Wiszniewski M; Kaminski MF; Kraszewska E; Mazurczak-Pluta T; Rzewuska D; Ptasinski A; Regula J
    Scand J Gastroenterol; 2014 Jul; 49(7):878-84. PubMed ID: 24797871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening.
    Schlichting JA; Mengeling MA; Makki NM; Malhotra A; Halfdanarson TR; Klutts JS; Levy BT; Kaboli PJ; Charlton ME
    J Am Board Fam Med; 2015; 28(4):494-7. PubMed ID: 26152441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.